Kell Lampin, LLC, an experienced Medical Device Litigation firm is now investigating Medtronic® Infuse® Lawsuits
Past News ReleasesRSS
St. Louis, MO (PRWEB) April 07, 2012
The nationwide defective medical device law firm of Kell Lampin, LLC is actively investigating Medtronic® Infuse® Lawsuits. The attorneys of Kell Lampin, LLC have over 30 years of experience in handling serious personal injury claims. The law firm's attorneys are currently providing free, no obligation, confidential case evaluations to persons injured by the BMP spine implant Infuse®.
The FDA has issued a public health notification regarding the use of BMP spinal implant, such as the Medtronic® Infuse® bone graft in cervical spinal fusions. In this notification the FDA linked such products to a variety of injuries including:
- Swelling of the neck and throat
- Swelling of the tongue and mouth
- Difficulty breathing
- Compression of the neurological structures in the neck
- Nerve damage
- Sever Dysphagia (difficulty swallowing)
The Infuse® BMP spinal implant was only approved by the FDA for use in spinal fusion surgeries using an anterior approach (through the front of the body). This approval was limited to the lumbar region of the spine. For more information about the FDA findings, visit: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062000.htm
In addition to the reports of such adverse effects, a recent issue of the Spine Journal (June, 2011) indicated numerous problems with the process in which the Medtronic® Infuse® bone graft product was approved by the FDA in the first place. The Spine Journal points to a variety of conflicts of interests between the doctors reporting to the FDA that may have gone unreported.
However, lawsuits are now being investigated across the nation due to information concerning off-label promotion of the BMP spinal implants. In the recent lawsuit of Minneapolis Firefighters' Relief Association et al v. Medtronic Inc et al, U.S. District Court, District of Minnesota, No. 08-06324, as reported by Reuters, it was alleged that as much as 85% of the sales of Infuse® were for off-label purposes. It is alleged that Medtronic® and its sales representatives may have promoted the off-label use of the spinal implant against FDA regulations. The lawsuit has now been settled for $85 million.
The attorneys of Kell Lampin, LLC are actively investigating Medtronic® Infuse® lawsuits based on these findings. The firm's attorneys have the experience and resources necessary to help those injured by the BMP spinal implant navigate the difficult and complex litigation process necessary to receive compensation for their injuries. The firm has handled numerous defective drug and defective medical device lawsuits on a nationwide basis and continues to help those suffering injuries from such products.
Kell Lampin, LLC’s main law offices are located in St. Peters, Missouri a suburb of St. Louis, Missouri. Located in the heart of the nation, the firm is able to help clients throughout the country facing devastating injuries from defective drugs and medical devices. Kell Lampin, LLC understands that facing the long litigation process can very hard on an individual and the family involved. Because of this, the attorneys of Kell Lampin, LLC have the goal of treating every case with the utmost respect and helping the families through the tough legal process.
For more information about injuries caused by the Infuse® BMP spinal implant, especially if such product was used in an off-label method, call the defective medical device litigation team of Kell Lampin today. An attorney will provide a free, no obligation, confidential evaluation of the case to see if it may be eligible for compensation through a lawsuit. Kell Lampin, LLC can be reached at 1-866-804-4357 or through the web at http://www.kelllampinlaw.com.